Crinetics Pharmaceuticals, Inc. (CRNX)
84.79
+0.10
(+0.12%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Gross Profit Margin (Quarterly) : 95.12% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.12% |
| March 31, 2026 | 87.33% |
| December 31, 2025 | 66.40% |
| September 30, 2025 | -607.7% |
| June 30, 2025 | 6.98% |
| March 31, 2025 | -156.2% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 45.28% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 69.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 85.37% |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Pfizer Inc. | 62.94% |
| Bristol Myers Squibb Co. | 67.95% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.94% |
| Return on Assets | -39.53% |
| Return on Invested Capital | -42.14% |
| Profit Margin (Quarterly) | -481.1% |
| Operating Margin (Quarterly) | -527.3% |
| Return on Net Operating Assets | -838.4% |